Pharma News, 2024

The FDA's Office of Generic Drugs reported a rise in generic drug approvals, as several first-time generics entered the market.

American Hospital Association or AHA urged healthcare facilities across the United States to disconnect from Change Healthcare.

Researchers from the US have discovered more than 275 million genetic variants identified through the National Institutes of Health’s (NIH) All of Us Research Program. ...

A Phase I trial studying the therapy is underway after an FDA clinical hold was lifted last year, with initial data expected in 2024.

The immune-mediated inflammatory bowel disease affects approximately 2.6 million people in Europe.

All patients in a trial have been offered the long-acting drug. Drugmaker is betting on injectable treatments for HIV.

Using a machine-learning algorithm, researchers can predict interactions that could interfere with a drug’s effectiveness.

Researchers from Imperial College London (ICL) have revealed that T cells could provide more protection in COVID-19 vaccines against Omicron, a SARS-CoV-2 virus strain, than antibodies do. ...

PHILADELPHIA -- WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, today announced that the U.S.

Recipients’ research focused on melanoma diagnosis, treatment response in advanced NSCLC, and bypassing common hurdles in NSCLC diagnosis and treatment